1) HBIG poly(butylcynaoacrylate) nanoparticle
HBIG聚氰基丙烯酸正丁酯纳米粒
2) Epirubicin Polybutylcyanoacrylate nanoparticles
表阿霉素聚氰基丙烯酸正丁酯纳米粒
1.
Objective To evaluate the therapeutic effects of Epirubicin Polybutylcyanoacrylate nanoparticles against transplanted malignant liver tumor in rats via vena caudalis.
目的观察表阿霉素和表阿霉素聚氰基丙烯酸正丁酯纳米粒对移植性肝癌的治疗效果。
3) PBCA-NP
聚氰基丙烯酸正丁酯纳米粒
1.
Vinblastine loaded poly(buty1 cyanoacrylate) nanoparticles(VLB-PBCA-NP) were prepared by emulsion polymerization process and using dextran as a stabilizing agent.
以右旋糖苷为稳定剂,通过乳化聚合法制备长春碱聚氰基丙烯酸正丁酯纳米粒,检测其基本性质(形态、粒径分布、包封率和载药量)。
4) MMC-PBCA-NP
丝裂霉素-聚氰基丙烯酸正丁酯-纳米粒
5) EPI-PBCA-NP
表阿霉素α-聚氰基丙烯酸正丁酯纳米粒
1.
Biological security preliminary assessment of a new type anti-tumor composite EPI-PBCA-NP;
表阿霉素α-聚氰基丙烯酸正丁酯纳米粒生物安全性的初步评价
2.
Object: To study the tolerable dose and the maximal toxicity-free concentration range of EPI-PBCA-NP when repeated doses were given to normal rats for a long time period, and to observe the target organs of the toxic action, the reversibility of tissue morphology and functions after withdrawal of EPI-PBCA-NP, so as to provide a theoretical basis for its clinical application.
目的：研究表阿霉素α-聚氰基丙烯酸正丁酯纳米粒(EPIpolybutylcyanoacrylate nanoparticles EPI-PBCA-NP)在长期重复给药情况下健康大鼠的耐受剂量，探索最大无毒性反应的安全剂量范围，毒副反应的靶器官以及停药后组织形态和功能的可逆情况，为临床试验提供依据。
6) mitomycin C-polybutylcyanoacrylate nanoparticles
丝裂霉素C聚氰基丙烯酸正丁酯纳米粒
补充资料：[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式：C16H16ClN3O3S
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条